Translational Research Institute
Translational Research Institute is a Brisbane-based, private for-profit research institute founded in 2012 with 501-1000 employees. It converts biomedical scientific findings into practical medical applications, serving the Australian translational medicine market.
- Company typePrivate
- Founded2012
- HeadquartersBrisbane, Australia
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Translational Research Institute does
Translational Research Institute (TRI) is a Brisbane, Australia-headquartered research institute founded in 2012 that occupies the translational medicine niche — converting scientific findings into practical medical applications. The organization is structured as a private for-profit entity with 501-1000 employees, distinguishing it from the more common university-hospital-affiliated non-profit translational research model in Australia. Its public positioning, captured on the tri.edu.au website under the tagline 'delivering impact,' centers on bridging laboratory science and clinical or commercial medical outcomes. Geographically the institute serves the Australian market only, with no international footprint disclosed.
From an operational perspective, TRI's 501-1000 employee scale implies a substantial physical research infrastructure and a multidisciplinary workforce spanning bench scientists, clinicians, translational specialists, and supporting technical and administrative staff. The source material does not enumerate specific research programs, named therapeutic areas, technology platforms, laboratory capabilities, or commercial product outputs. Consequently, the institute's underlying scientific and technical stack cannot be characterized beyond the general translational medicine framing.
The business model is not specified in source data. Pricing is flagged as not applicable, no customer logos or contracted clients are documented, and no partnerships, alliances, or industry collaborators are listed. The for-profit classification is the only signal about revenue mechanics, suggesting at least some component of commercial income (industry partnerships, licensing, fee-for-service) sits alongside likely grant and government funding typical of Australian biomedical research institutes. The lack of disclosed financial information and customer base makes any revenue or business model characterization tentative.
Translational Research Institute firmographics
Firmographics- Name
- Translational Research Institute
- Legal name
- Translational Research Institute Australia
- Website
- https://tri.edu.au
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Translational Research Institute is a Brisbane-based, private for-profit research institute founded in 2012 with 501-1000 employees. It converts biomedical scientific findings into practical medical applications, serving the Australian translational medicine market.
- Ownership category
- akta.pro rank
Translational Research Institute industry classification
Industry- Product category
- Biomedical Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industries
- Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
Keywords
Where Translational Research Institute is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Translational Research Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Translational Research Institute product offering
Product offeringCore offering
Translational Research Institute (TRI) is a Brisbane-based medical research institute that converts scientific discoveries into practical clinical and medical applications. It operates as a research facility providing translational research infrastructure and capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Translational Research Services
Companies that use Translational Research Institute
Customer profileIdeal customer profiles1 record
Translational Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Translational Research Institute partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights1 record
Translational Research Institute competitors and assessment
Company assessmentRegional players
- Peter MacCallum Cancer Centre: Melbourne-based integrated cancer research and treatment centre that combines clinical care with translational laboratory research — comparable as a translational research entity in Australia with hospital integration.
- Murdoch Children's Research Institute: Melbourne-based paediatric medical research institute with major translational programs in child health, genetics, and rare disease — comparable in scale, translational mission, and Australian not-for-profit research institute structure.
- Baker Heart and Diabetes Institute: Melbourne-based independent medical research institute specialising in cardiovascular, metabolic, and diabetes research with translational pipelines — comparable as an Australian disease-focused translational institute with overlapping operating model.
Direct peers
- Garvan Institute of Medical Research: Sydney-based medical research institute conducting genomic, cancer, and immune disorder research with strong translational pipelines into clinical practice — comparable as an Australian translational research institute with similar scale and mission.
- Centenary Institute: Sydney-based independent medical research institute focused on cancer, cardiovascular disease, and inflammatory diseases with translational research programs — comparable in scope, scale, and translational mission to TRI.
- QIMR Berghofer Medical Research Institute: Australian translational medical research institute based in Brisbane focused on converting laboratory discoveries into clinical outcomes across cancer, infectious disease, and mental health — directly comparable in mission, geography, and translational focus to TRI.
- Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute based in Melbourne, focused on cancer, immune disorders, and infectious disease with significant translational outputs and commercialization — a closely comparable translational research institute at larger scale.
- Harry Perkins Institute of Medical Research: Perth-based medical research institute with programs across cancer, cardiovascular, and metabolic disease emphasising translational outcomes — similar Australian translational research institute with comparable mission.
- South Australian Health and Medical Research Institute (SAHMRI): Adelaide-based independent health and medical research institute delivering translational research across multiple therapeutic areas — directly comparable as an Australian translational research entity of similar scale.
Emerging players
- Stowers Institute for Medical Research: US-based independent biomedical research organisation focused on fundamental and translational research in gene regulation and regeneration — comparable as a privately-funded translational research institute outside Australia, useful for international benchmarking.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Translational Research Institute social profiles
Digital presenceTranslational Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Translational Research Institute leadership team
Management profileNumber of profiles
Translational Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Translational Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Translational Research Institute
What does Translational Research Institute do?
Translational Research Institute (TRI) is a Brisbane-based medical research institute that converts scientific discoveries into practical clinical and medical applications. It operates as a research facility providing translational research infrastructure and capabilities.
Is Translational Research Institute a public or private company?
Translational Research Institute is a private company. It is classified as unknown and is currently operating.
When was Translational Research Institute founded?
Translational Research Institute was founded in 2012. It employs 501 to 1,000 people.
Where is Translational Research Institute based?
Translational Research Institute is headquartered in Brisbane, Australia, in the Oceania region.
Who are Translational Research Institute's main competitors?
Regional players on record are Peter MacCallum Cancer Centre, Murdoch Children's Research Institute and Baker Heart and Diabetes Institute. Direct peers are Garvan Institute of Medical Research, Centenary Institute, QIMR Berghofer Medical Research Institute, Walter and Eliza Hall Institute of Medical Research (WEHI), Harry Perkins Institute of Medical Research and South Australian Health and Medical Research Institute (SAHMRI). Stowers Institute for Medical Research is listed as an emerging player.
Does Translational Research Institute have an API?
No public API is recorded for Translational Research Institute.
What industry is Translational Research Institute in?
Translational Research Institute's product category is Biomedical Research. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization). Its NAICS code is 541714 and its SIC code is 8731.